AwardTape · Defense awards · Research and development · Health R&D · HT009025FG1210017
HT009025FG1210017: $24K BPA call to Harvard Bioscience Inc
Harvard Bioscience Inc holds a BPA call from Defense Health Agency with $24K obligated since Oct 2023, against a ceiling of $24K. Latest action Dec 5, 2024.
Medical research implants.
| PIID | HT009025FG1210017 |
|---|---|
| Type | BPA call |
| Parent award | W81XWH22A0001 |
| Company | Harvard Bioscience Inc |
| Agency | Defense Health Agency |
| Contracting office | GPC COMPONENT PROGRAM MANAGER |
| Category | Research and development · Health R&D |
| PSC | AN23 HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; EXPERIMENTAL DEVELOPMENT |
| NAICS | 339113 SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING |
| Obligated since Oct 2023 | $24K |
| Total obligated (lifetime) | $24K |
| Ceiling (base and all options) | $24K |
| Base date | Dec 5, 2024 |
| Latest action | Dec 5, 2024 |
| End date | Sep 30, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | MN |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial